Downgrades by analysts can lead to a negative perception among investors and potentially cause a short-term decline in the stock price. The change from Outperform to Market Perform suggests that the analyst believes Illumina may not outperform the market as previously expected, which could lead to a decrease in investor confidence and a subsequent drop in the stock price.